Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling
Open Access
- 1 September 2012
- journal article
- research article
- Published by Elsevier BV in Annals of Oncology
- Vol. 23 (suppl_10), x271-x277
- https://doi.org/10.1093/annonc/mds357
Abstract
Carcinoma of unknown primary (CUP) remains a common and challenging clinical problem. The aim of diagnostic work-up in CUP is to classify as specifically as possible the cancer affecting the patient, according to the broad tumour type, subtype and, where possible, site of origin. This classification currently best predicts patient outcome and guides optimal treatment. a stepwise approach to diagnostic work-up is described. although pathology is based on morphology, the assessment of tissue-specific genes through immunohistochemistry (IHC) substantially helps tumour classification at each diagnostic step. For IHC in CUP, recent improvements include more standardised approaches and marker panels plus new markers. Tissue-specific genes are also being used in CUP work-up through molecular profiling. Large-scale profiles of hundreds of tumours of different types have been generated, compared and used to generate diagnostic algorithms. Commercial tests for CUP classification have been developed at the mRNa and microRNa (miRNa) levels and validated in metastatic tumours and CUPs. While currently optimal pathology and IHC remain the ‘gold standard’ for CUP diagnostic work-up, and full clinical correlation is vital, the molecular tests appear to perform well: in the main diagnostic challenge of undifferentiated or poorly differentiated tumours, molecular profiling performs as well as or better than IHC.This publication has 46 references indexed in Scilit:
- Carcinomas of an unknown primary origin—diagnosis and treatmentNature Reviews Clinical Oncology, 2011
- Performance and Clinical Evaluation of the 92-Gene Real-Time PCR Assay for Tumor ClassificationThe Journal of Molecular Diagnostics, 2011
- Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2011
- A DNA methylation fingerprint of 1628 human samplesGenome Research, 2011
- Validation and Reproducibility of a Microarray-Based Gene Expression Test for Tumor Identification in Formalin-Fixed, Paraffin-Embedded SpecimensThe Journal of Molecular Diagnostics, 2011
- Classification of unknown primary tumors with a data-driven method based on a large microarray reference databaseGenome Medicine, 2011
- NKX3.1 as a Marker of Prostatic Origin in Metastatic TumorsThe American Journal of Surgical Pathology, 2010
- A taxonomy of epithelial human cancer and their metastasesBMC Medical Genomics, 2009
- An Abundance of Ubiquitously Expressed Genes Revealed by Tissue Transcriptome Sequence DataPLoS Computational Biology, 2009
- ISOLATE: a computational strategy for identifying the primary origin of cancers using high-throughput sequencingBioinformatics, 2009